news paper icon

Analyzed News

REFILE-FDA declines to approve Evolus Inc's rival treatment to Botox

May 16 (Reuters) - U.S. health regulators on Wednesday declined to approve Evolus Inc's rival product to Allergan Plc's Botox, citing certain deficiencies related to its potential treatment for frown lines. [Source]

Publication Date:

Origin: reuters.com

Category: companyNews

Topics: inc's, treatment, botox, rival, evolus

Source Link: http://feeds.reuters.com/~r/reuters/companyNews/~3/0ll3g6Tf2Ms/refile-fda-declines-to-approve-evolus-incs-rival-treatment-to-botox-idUSL3N1SN4U4

Related Articles